Clinical Evaluation |
---|
Glucose metabolism |
Type of Imaging |
PET |
Grade of Recommendation |
C/D (optional) |
Level of Evidence |
well-established clinical and Nuclear Medicine recommendations |
Effective Dose |
19.0 µSv/MBq |
Bibliographic Reference |
Taïeb, D., Hicks, R.J., Hindié, E., Guillet, B.A., Avram, A., Ghedini, P., Timmers, H.J., Scott, A.T., Elojeimy, S., Rubello, D., Virgolini, I.J., Fan...
read more
Taïeb, D., Hicks, R.J., Hindié, E., Guillet, B.A., Avram, A., Ghedini, P., Timmers, H.J., Scott, A.T., Elojeimy, S., Rubello, D., Virgolini, I.J., Fanti, S., Balogova, S., Pandit-Taskar, N., Pacak, K. European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019; https://doi.org/10.1007/s00259-019-04398-1
read less
|
Guide to Nuclear Medicine |
Read the corresponding chapter |